Viewing Study NCT00678392


Ignite Creation Date: 2025-12-24 @ 3:43 PM
Ignite Modification Date: 2026-02-03 @ 10:12 AM
Study NCT ID: NCT00678392
Status: COMPLETED
Last Update Posted: 2019-01-09
First Post: 2008-05-12
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Axitinib (AG 013736) As Second Line Therapy For Metastatic Renal Cell Cancer
Sponsor:
Organization: